● FDA CSAOverviewSource LibraryArticles & ClausesApplicabilityInterpretationEvidence ReadinessAI GovernanceOperational FlowActors & ServicesUpdates & Assets
Regulations/FDA CSA
FDA CSA · regulatory evidence-readiness

CSA moves validation from paperwork to assurance.

This workspace reads FDA CSA as an operational shift: intended use, patient/product/process risk, assurance activity, scripted or unscripted testing where appropriate, objective evidence, and fit-for-purpose records.

Source basis: Computer Software Assurance for Production and Quality System SoftwareUse: evidence-readinessBoundary: not legal advice
FDA CSA TRACE FDA CSA FINAL GUIDQMSR TERMINOLOGYPRODUCTION SOFTWQUALITY MANAGEME
/ Workspace scope

What this workspace makes usable.

FDA CSA

Computer Software Assurance for Production and Quality System Software is mapped here for regulated life-sciences, health-tech, AI governance, and operational quality work. FDA guidance for risk-based assurance of software used in medical device production and quality systems.

Guidance is nonbinding. iFeed maps CSA into assurance records and practical QMS evidence, not a validation prescription.

Work object 01

Intended use

Assurance starts with what the software is used for in the quality or production process.

Work object 02

Risk-based assurance

Higher-risk use needs stronger evidence; lower-risk use can avoid unnecessary burden.

Work object 03

Assurance activity selection

Testing approach should match risk and use, not follow a fixed ritual.

Work object 04

Objective evidence

Records should show what was checked, by whom, with what result.

Work object 05

Unscripted testing

Exploratory and ad hoc testing may be appropriate when justified and documented.

Work object 06

Automation support

Tools can support assurance but need their own fit-for-use rationale.

Work object 07

Change control

Software changes need traceable impact and assurance decisions.

Work object 08

QMS link

CSA sits inside production and quality system controls, not outside them.

/ Current source anchors

Primary references stay visible.

official first
Official FDA guidance

FDA CSA guidance

2026-02 · Current final guidance on computer software assurance for production and quality management system software; it supersedes the September 2025 final guidance.

open
Official FDA PDF

FDA CSA guidance PDF

2026-02 · Guidance history notes February 2026 revisions to align terminology with QMSR amendments to Part 820.

open
/ Foundation route

The workspace can grow without breaking the source trail.

stable structure
Structure

The ten subchapters are fixed surfaces for future public assets.

Overview · Source Library · Articles & Clauses · Applicability · Interpretation · Evidence Readiness · AI Governance · Operational Flow · Actors & Services · Updates & Assets

10